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Mouse modelWest Nile virus (WNV) is a mosquito-borne ﬂavivirus which causes important morbidity and mortality in
birds, horses and humans. In the Western Mediterranean region, WNV causes sporadic, self-limited
outbreaks, with few or no human cases. Here we report the characterization of two recent Western
Mediterranean WNV isolates, obtained in Spain in 2007 from two golden eagles. Complete genome sequence
comparisons revealed high identity between these isolates and close relationship with other Western
Mediterranean WNV strains isolated since 1996. Phylogenetic analysis within this group indicated that two
distinct phylogenetic groups have emerged from earlier strains. Pathogenicity analysis in mice showed that
the Spanish isolate is less pathogenic than other strains either from the Western Mediterranean (Morocco
2003) or from North America (NY'99). Changes in amino acid position NS3-249 (claimed as a virulence
marker) did not inﬂuence the pathogenicity observed.
© 2009 Elsevier Inc. All rights reserved.Introduction
West Nile virus (WNV) is an arthropod-borne ﬂavivirus affecting a
wide range of vertebrates, including birds, reptiles, amphibians and
mammals. Enzootic (sylvatic) cycle is sustained between mosquitoes
and wild birds, which are reservoir hosts. In some instances, a
spillover occurs from the enzootic cycle, triggering an “urban” cycle,
most often affecting peridomestic birds, horses and humans. Neither
horses nor humans are thought to be able to transmit the virus, and
are considered “dead-end” hosts. Humans infected by WNV may
develop a variety of symptoms, from a mild fever to a more severe
neuroinvasive illness that can be fatal in a small percentage (b1%) of
cases (reviews by Brault, 2009; Granwehr et al., 2004; Hayes et al.,
2005; Kramer et al., 2008; McLean et al., 2002). Most WNV infections
in avian hosts are asymptomatic, and viral circulation often remainsasar, s/n, 28130, Valdeolmos
@inia.es (J. Fernandez-Pinero),
güero), ursula.hoﬂe@uclm.es
), majimenez@inia.es
tra Algete, km 8, 28110, Algete
ll rights reserved.unnoticed. However, the virus can cause severe disease in different
species of birds. Some passerines, particularly corvids, are highly
susceptible to the disease (Komar et al., 2003). Different types of
raptors have also been identiﬁed as susceptible hosts (Nemeth et al.,
2006; Bakonyi et al., 2006; Erdélyi et al., 2007; Höﬂe et al., 2008).
Birds are believed to carry the virus over long distances during
migration, this being the most likely way for the introduction of the
virus to Europe and the Mediterranean region from endemic areas of
sub-Saharan Africa (Berthet et al., 1997; Charrel et al., 2003; Jourdain
et al., 2007a).
The genome ofWNV is approximately 11,000 nucleotides in length,
depending on the strain, with three structural genes (capsid [C],
membrane [prM-M] and envelope [E]) and seven nonstructural genes
(NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5). Phylogenetically, WNV
is divided into two major lineages. Lineage 1 predominates in North
America, Asia, Europe, the Middle East and Northern Africa. Lineage 2
is found primarily in Africa, though it has been also observed in
Central (Bakonyi et al., 2006) and Eastern (Shopenskaya et al., 2007)
Europe since 2004. Additional WNV lineages have also been proposed
recently (Bakonyi et al., 2005; Bondre et al., 2007).
West Nile virus has been recognized for a long time in southern
Europe, causing sporadic outbreaks usually involving localised
regions, with few clinical—human and/or animal—cases, separated
Table 1
West Nile virus nucleotide sequences used in the phylogenetic study carried out in this
work.
WNV isolate/strain name GenBank accession number
Spain/2007 GE-1b/Ba FJ766331
Spain/2007 GE-2o/Va FJ766332
France 407/04 DQ786573
France 405/04 DQ786572
Italy 15803/08 FJ483549
Italy 15217/08 FJ483548
Morocco/03 AY701413
Italy/98 AF404757
France/00 AY268132
Morocco/96 AY701412
Kenya/98 AY262283
Romania/96 AF260969
Volgograd/99 human AF317203
Astrakhan/01 cormorant DQ411029
Astrakhan/04-2-824A DQ374652
Astrakhan/02 dove DQ411032
Tunisia/97 AY268133
Hungary/03 DQ118127
Mexico/03 AY660002
Israel/98 AF481864
New York/00 crow EF657887
New York/99 human AF202541
New York/99 ﬂamingo AF196835
China AY490240
Egypt/51 AF260968
Portugal/71 AM404308
Kunjin D00246
a New sequences described in this work.
290 E. Sotelo et al. / Virology 395 (2009) 289–297by long periods of epidemiological silence (Hubálek and Halouzka,
1999; Murgue et al., 2001a). This contrasts with the epidemiology
observed in North America (Zeller and Schuffenecker, 2004) where,
since its ﬁrst appearance in 1999, the virus has spread relentlessly,
causing a severe epidemic of important consequences for public
health, livestock and wildlife (Reisen and Brault, 2007). In the
Western Mediterranean, ﬁrst isolates were obtained in the Camargue
(France) in 1962. The virus was also isolated frommosquitoes in 1971
in Portugal (Filipe, 1972), but since then no virus activity was
detected in the region until 1996, where it reappeared causing
disease in horses in Morocco (El Harrak et al., 1997). This episode was
followed by increasing WNV activity in this area, corroborated by
WNV isolation in several countries (Morocco, 1996 and 2003; Italy,
1998 and 2008; Portugal, 2004; France, 2000, 2004 and 2006; Spain,
2007) (Murgue et al., 2001b; Schuffenecker et al., 2005; Autorino et
al., 2002; Esteves et al., 2005; Jourdain et al., 2007b; Jiménez-Clavero
et al., 2008; Savini et al., 2008).
In Spain, WNV circulation has been revealed only very recently,
when comprehensive studies have been undertaken. While in wild
birds serological surveys in southern wetlands have identiﬁed species
exposed to the infection (Figuerola et al., 2007a; Figuerola et al., 2008;
López et al., 2008), and species involved in an enzootic cycle
(Figuerola et al., 2007b), in humans, very low seroprevalence to
WNV has been observed (Boﬁll et al., 2006; Bernabeu-Wittel et al.,
2007), and only one single case of WNV infection has been diagnosed
to date (Kaptoul et al., 2007). Despite this low activity, WNV genome
and/or speciﬁc antibodies have been repeatedly detected in raptors in
central Spain, particularly in endangered eagles such as imperial eagle
(Aquila adalbertii), golden eagle (Aquila chrysaetos) and Bonnelli's
eagle (Hieraaetus fasciatus) (Höﬂe et al., 2008). In September 2007, a
WNV outbreak affected raptors in a captive breeding and rehabilita-
tion centre in Central Spain. The virus was isolated from two golden
eagles showing symptoms of the disease (Jiménez-Clavero et al.,
2008). In this paper we provide a detailed characterization of two
isolates, named GE-1b/B and GE-2o/V, from the two eagles. This
characterization involves, on one hand, the nucleotide sequence of
their complete genomes, which has allowed us to carry out a new
phylogenetic study of the Western Mediterranean isolates. On the
other hand, the derived amino acid sequence of the new isolates
revealed changes of putative relevance for virulence (namely, a
proline residue found in position 249 of the NS3 nonstructural protein
of the virus, that has recently been implicated as being involved in
virulence for American Crows) (Brault et al., 2007) which prompted
us to perform a pathogenicity study in a mouse model. In this study
we compared the lethal dose 50 (LD50) of fourWNV isolates: one from
this study, namely, Spain/2007 (GE1b/B), a second isolate from the
Western Mediterranean (Morocco/2003), one from North America
(NY'99-crow, North American strain) and one from Africa (B956,
Uganda, 1937, WNV prototype strain).
Material and methods
Virus isolates and strains
The two new West Nile virus isolates analyzed in this study were
obtained from two golden eagles (A. chrysaetos) (named GE-1, index
case, lethally infected, and GE-2, secondary case, surviving the
infection) found infected with WNV in Central Spain in 2007, as
described (Jiménez-Clavero et al., 2008). The isolates were named
after the origin and isolation procedure, as “GE-1b/B” (GE-1, brain/
BSR cells) and “GE-2o/V” (GE-2, oropharyngeal/Vero cells). In brief,
isolate GE-1b/B was obtained after inoculation of ﬁlter-sterilized
clariﬁed brain tissue homogenate, obtained from GE-1, in BSR cell
cultures (cell line derived from BHK-21 baby hamster kidney cells),
whereas isolate GE-1o/V was obtained after inoculation of ﬁlter-
sterilized oropharyngeal swab extract from GE-2 in Vero cell cultures(African green monkey kidney-derived cells, ATCC n°: CCL-81).
Cytopathic effect (CPE) was observed after a single passage in BSR
cells and after two passages in Vero cells. West Nile virus was
conﬁrmed in infection supernatants from all CPE-positive wells by
using real-time and conventional RT-PCR performed as described
(Jiménez-Clavero et al., 2006; Scaramozzino et al., 2001). In order to
obtain sufﬁcient RNA for full-length nucleotide sequence analysis, the
isolates were further propagated in cell culture. The isolate from BSR
cells required one more passage in the same cells, whereas the isolate
from Vero cells required two passages in Vero cells. Another two
isolates were also obtained from spleen and kidney of the diseased
eagle (GE-1), which are not analyzed in this study.
Other WNV strains used in this study were B956 (WNV prototype
strain, human, Uganda, 1937, lineage 2, GenBank acc. n° AY532665),
obtained through the American Type Culture Collection (ATCC, cat. n°:
VR1510); NY'99 (WNV North American strain, crow, New York, 1999,
GenBank acc. n° FJ151394, obtained through the National Veterinary
Service Laboratories, USDA (lot number 034EDV0601); and Morocco/
2003 (strain name: 04.05, Morocco, 2003, horse, GenBank acc. n°:
AY701413), obtained through the Spanish National Reference Labora-
tory for viral zoonoses (Laboratorio Nacional de Veterinaria, Algete,
Spain).
All the viruses employed in this workwere propagated and titrated
by plaque assays in Vero cells. Virus titers were given in plaque
forming units (pfu).
RNA extraction, WNV genome ampliﬁcation and sequencing
Total RNA was automatically extracted from 100 μl of infected cell
culture supernatants with Biosprint 15 workstation, according to the
manufacturer's protocol. RNA was eluted in a ﬁnal volume of 100 μl
RNase-free water and stored at −70 °C until used.
The complete WNV nucleotide sequence of both isolates was
obtained using 25 different primer sets previously described (Jour-
dain, 2006), plus one newly designed primer pair, amplifying
overlapping amplicons that were sequenced on both strands (primer
sequence details available from authors upon request). One-step RT-
Fig. 1. (a) Phylogenetic tree of 27 complete WNV nucleotide sequences, including two isolates from golden eagles (GE-1b/B and GE-2o/V, respectively) sequenced in this study
(closed circles). The percentage of successful bootstrap replicates (n=1000) is indicated at nodes. Branch lengths are proportional to the number of nucleotide changes (genetic
distances). Scale bar shows number of base substitutions per site. All isolates belong to clade 1awithin lineage 1 except Kunjin (outgroup) which belongs to clade 1b. (b) Detail of the
phylogenetic tree shown in (a), in which the branch comprising all the Western Mediterranean isolates analyzed in this study is highlighted.
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292 E. Sotelo et al. / Virology 395 (2009) 289–297PCR kit (Qiagen) was used to run conventional RT-PCR assays,
following manufacturer's instructions. Ampliﬁcation products were
analysed by electrophoresis on 2% agarose gels containing 0.5 μg/ml of
ethidium bromide.
Ampliﬁed DNAswere puriﬁed using ExoSAP-IT kit (GE Healthcare),
and then bidirectionally sequenced by automatic dideoxy cycle
sequencing techniques, Big Dye Terminator (version 3.1) Cycle
Sequencing Kit, and an ABI 3730 XL DNA Analyzer, using the same
primer sets of the RT-PCR assays.
Sequence and phylogenetic analysis
Raw sequence data were assembled and analyzed using speciﬁc
SeqScape software (Applied Biosystems). Sequences for the WNV
isolates GE-1b/B and GE-2o/V were submitted to GenBank (Nucleo-
tide ID: FJ766331 and FJ766332, respectively). Whole-genome
sequences were aligned by MEGA 4 software using ClustalW
algorithm (Tamura et al., 2007). Phylogenetic analyses were carried
out by two methods: on one hand, neighbour-joining trees (Saitou
and Nei, 1987) were constructed from genetic distances matrices
computed with the Kimura two-parameter method Kimura, 1980),
with 1000 bootstrap replicates to estimate the tree robustness
(Felsenstein, 1985). On the other hand, maximum likelihood estima-
tion of phylogenetic trees (Guindon and Gascuel, 2003; Keane et al.,
2007) was also applied as an alternative method. All positions
containing alignment gaps and missing data were eliminated only in
pairwise sequence comparisons. There were a total of 11,108 positions
in the ﬁnal dataset. All isolates in the alignment belong to clade 1a
within lineage 1 except Kunjin (outgroup) which belongs to clade 1b.
They are listed, together with their GenBank accession numbers, in
Table 1.
Pathogenicity and determination of 50% lethal dose (LD50) in mice
Swiss HSD ICR (CD1) outbred mice were purchased from Harlan,
Inc. (Switzerland), maintained in a BSL3 facility according to the CISA
guidelines and used in protocols supervised and approved by the
Ethics and Animal Welfare Committees of the Instituto Nacional de
Investigación y Tecnología Agraria y Alimentaria (INIA). Groups of six
3- to 4-week-old Swiss mice were inoculated intraperitoneally with
different doses (100–104 plaque forming units, pfu) of infectious WNV
belonging to the following isolates/strains: Spain/2007 (GE-1b/B),
Morocco/2003 (04.05), NY'99 (crow) and B956, whose characteristicsTable 2
Nucleotide changes for the Spain/2007 GE-1b/B WNV isolate (GenBank acc. n°: FJ766331)
(Morocco 2003, sequenced from nt 38 to 10,986); AY268132 (France 2000, sequenced from n
sequenced from nt 20 to 10,962); FJ483548 (Italy 2008); AF196835 (New York 1999); AY28
Region Length
(n° of nt)
Italy
1998
Morocco
2003
France
2000
Morocco
1996
N° % N° % N° % N° %
5′-NC 81a 0 0.00 0 0.00 0 0.00 0 0.00
C 369 2 0.54 1 0.27 5 1.36 1 0.27
Pr M 276 1 0.36 0 0.00 2 0.72 2 0.72
M 225 7 3.11 6 2.67 5 2.22 9 4.00
E 1503 16 1.06 25 1.66 15 1.00 17 1.13
NS1 1056 12 1.14 14 1.32 18 1.70 12 1.14
NS2A 693 12 1.73 14 2.02 12 1.73 9 1.30
NS2B 393 3 0.76 7 1.78 5 1.27 7 1.78
NS3 1857 24 1.29 27 1.45 31 1.67 24 1.29
NS4A 447 6 1.34 6 1.34 4 0.89 6 1.34
NS4B 764 6 0.78 9 1.18 10 1.31 9 1.18
NS5 2715 31 1.14 34 1.25 33 1.22 33 1.22
3′.NC 581a 7 1.20 4 0.69 6 1.03 3 0.51
Total 10,960a 127 1.16 147 1.34 146 1.33 132 1.20
Numbering according to GenBank AF196835 sequence.
a Comparisons against the trimmed sequence obtained from WNV isolate Spain/2007 GEhave been already described above in this section. A group of six mice
inoculated in parallel with an equivalent volume (0.1 ml) of cell
culture medium was maintained as a control. Mice were monitored
daily for symptoms and death, up to 4 weeks after inoculation (when
they were euthanized), and mortality rate of each group was used to
calculate the LD50 (50% lethal dose) by the Reed and Muench (1938)
method for each of the viruses tested in this assay. Neuroinvasiveness
was evaluated by post-mortem analysis of brain tissue by real-time
RT-PCR (Jiménez-Clavero et al., 2006) and virus isolation in cell
culture (Vero cells). Virus replication in other target tissues (liver,
kidney) was also monitored in the same way. Neutralizing antibodies
in sera from surviving mice at 28 days post-infection (dpi) were also
analyzed as described elsewhere (Figuerola et al., 2007a).
Results
Nucleotide sequence and phylogenetic analysis
Unambiguous nucleotide sequences were obtained encompassing
nucleotide positions 16–10,976 of the genomes of the two WNV
isolates analyzed in this study (GE-1b/B and GE-2o/V, respectively).
Pairwise alignment of these sequences revealed that they differ in
only six nucleotide positions (99.94% identity), namely, 5275, 5400
(within the NS3-coding region), 7532 (NS4B-coding region), 8961,
9003 and 10182 (NS5-coding region) (numbering according to
GenBank ID AF196835), none of them encoding changes in amino
acid residues, so the derived amino acid sequences from both isolates
were completely identical. We chose the isolate GE-1b/B, from the
index case, as the representative—or prototype—strain of the Spanish
WNV isolates, that will be referred to as “Spain/2007” hereafter.
Multiple alignments of the Spanish WNV sequences and 25 full-
length genomes belonging to different WNV strains and isolates,
available in GenBank (Table 1), were carried out, which allowed
generating a phylogenetic tree that showed a high relatedness
between these new sequences and all Western Mediterranean strains
obtained since 1996 from which full-length nucleotide sequence is
available, namely (in chronological order), Morocco/1996, Italy/1998,
France/2000, Morocco/2003, France/2004 (France 407/04 and
France 405/04) and Italy/2008 (Italy 15804/08 and Italy 15217/08),
all of them belonging to lineage 1, clade 1a (Fig. 1a). This Western
Mediterranean subclade constitutes a monophyletic group in the tree
(Fig. 1b). Paired identity with these strains at the nucleotide level
ranged between 98.24% and 98.79%, whereas with other strains withinrelative to other lineage 1 strains: GenBank acc. n° AF404757 (Italy 1998); AY701413
t 16 to 11,009; Morocco 1996, sequenced from nt 38 to 10,986); DQ786573 (France 2004,
9214 (Beaumont 2002); AF481864 (Israel 1998).
France
2004
Italy-1
2008
New York
1999
Beaumont
2002
Israel
1998
N° % N° % N° % N° % N° %
0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
5 1.36 3 0.81 4 1.08 5 1.36 5 1.36
3 1.09 1 0.36 7 2.54 7 2.54 7 2.54
7 3.11 5 2.22 13 5.78 13 5.78 13 5.78
26 1.73 28 1.86 47 3.13 50 3.33 49 3.26
14 1.32 12 1.14 39 3.69 42 3.98 40 3.79
12 1.73 13 1.87 27 3.90 29 4.18 31 4.47
8 2.03 8 2.03 18 4.58 18 4.58 21 5.34
31 1.67 30 1.61 81 4.36 82 4.41 83 4.47
8 1.79 13 2.91 13 2.91 14 3.13 13 2.91
16 2.09 12 1.57 34 4.45 34 4.45 33 4.32
37 1.36 44 1.62 96 3.53 100 3.68 102 3.76
8 1.41 8 1.38 23 3.96 24 4.13 23 3.96
175 1.60 177 1.61 402 3.67 418 3.81 420 3.83
-1b/B (nt 16–10,976 of WNV).
Table 3
Amino acid changes and percentage identity for the Spain/2007 GE-1b/B isolate, relative to other lineage 1 strains (same as in Table 2).
Viral
protein
N° of
amino acids
Italy
1998
Morocco
1996
Morocco
2003
France
2000
France
2004
Italy
2008
New York
1999
Beaumont
2002
Israel
1998
N° % N° % N° % N° % N° % N° % N° % N° % N° %
C 123 1 0.81 1 0.81 1 0.81 1 0.81 3 2.44 1 0.81 1 0.81 1 0.81 1 0.81
PrM 92 0 0.00 0 0.00 0 0.00 0 0.00 1 1.09 0 0.00 0 0.00 0 0.00 0 0.00
M 75 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00
E 501 2 0.40 3 0.60 2 0.40 2 0.40 4 0.80 2 0.40 4 0.80 5 1.00 4 0.80
NS1 352 3 0.85 4 1.14 4 1.14 4 1.14 5 1.42 3 0.85 4 1.14 5 1.42 5 1.42
NS2A 231 0 0.00 0 0.00 1 0.43 1 0.43 0 0.00 1 0.43 0 0.00 0 0.00 1 0.43
NS2B 131 1 0.76 0 0.00 0 0.00 0 0.00 0 0.00 1 0.76 1 0.76 1 0.76 3 2.29
NS3 619 1 0.16 1 0.16 2 0.32 3 0.48 1 0.16 0 0.00 1 0.16 1 0.16 3 0.48
NS4A 149 0 0.00 0 0.00 0 0.00 0 0.00 0 0.00 2 1.34 1 0.67 1 0.67 1 0.67
NS4B 255 1 0.39 1 0.39 1 0.39 1 0.39 1 0.39 1 0.39 2 0.78 3 1.18 2 0.78
NS5 905 2 0.22 2 0.22 2 0.22 3 0.33 3 0.33 4 0.44 2 0.22 3 0.33 5 0.55
Total 3433 11 0.32 12 0.35 13 0.38 15 0.44 18 0.52 15 0.44 16 0.47 20 0.58 25 0.73
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the similarity was lower, ranging from 96.18% (Israel/1998) to 96.36%
(NY'99) (Table 2). Noteworthy, Spain/2007 showed higher nucleotide
sequence identity to WNV Italy/1998 than to any other WNV. On the
other hand, the recent Italian isolates (Italy 15804/08 and Italy 15217/
08) showed more relatedness to WNV France 405/2004, France 407/
2004 and Morocco/2003, than to Spain/2007 and Italy/1998 isolates
(Fig. 1b). Thus, within the Western Mediterranean subclade, the
analysis revealed that recentWesternMediterranean isolates separate
into two main phylogenetic groups. Besides, the isolate France/2000
remain unresolved (37% bootstrap support) in this analysis. The
phylogenetic tree obtained applying a different (maximum likelihood
estimation) method showed essentially the same result (not shown),
further supporting that recent Western Mediterranean strains form
two distinct phylogenetic groups.
Comparison of the derived amino acid sequence of the WNV
polyprotein precursor (3433 amino acid residues) from the Western
Mediterranean isolates demonstrated also the closest relationship
between Spain/2007 and Italy/1998 (11 amino acid substitutions).
Most variation in amino acid positions between the isolates compared
in this study corresponds to the nonstructural protein NS1 (Table 3).
Remarkably, a signiﬁcant (pb0.05) increase was observed between
the number of amino acid substitutions among the isolates obtained
between 1996 and 2003 (mean: 5.83; SD: 1.60) and the isolates
obtained since 2004 (mean: 13.83; SD: 5.41) (Table 4).
Looking into the amino acid substitutions in more depth, a total of
nine positions were unique to the Spain/2007 isolates, which were
not shared either with any of the sixWesternMediterranean strains or
with three representative American/Israeli strains included in the
alignment, and could be considered as “signature” for the Spain/2007
WNV (Table 5). Between the American/Israeli and the Western
Mediterranean strains there were six substitutions that were
characteristic (“signatures”) of each cluster (Table 5). Remarkably,
one amino acid position, NS3-249, typically occupied by proline (P) in
the American/Israeli strains, and mostly occupied by threonine (T) inTable 4
Number of amino acid substitutions and (in parenthesis) percentage of amino acid diverge
strains (GenBank accession numbers indicated in previous tables).
Morocco 1996 Italy 1998 France 2000 Morocco 2
Morocco 1996 —
Italy 1998 4 (0.12%) —
France 2000 8 (0.23%) 6 (0.17%) —
Morocco 2003 6 (0.17%) 4 (0.12%) 7 (0.20%) —
France 2004 11 (0.32%) 9 (0.26%) 13 (0.38%) 11 (0.32%)
Spain 2007 12 (0.35%) 11 (0.32%) 15 (0.44%) 13 (0.38%)
Italy 15804/08 9 (0.26%) 6 (0.17%) 12 (0.35%) 10 (0.29%)
Italy 15217/08 10 (0.29%) 9 (0.26%) 13 (0.38%) 11 (0.32%)the Western Mediterranean strains (with the exception of Morocco/
1996, which shows alanine [A] instead), is occupied by P as well both
in the Spain/2007 and Italy/2008 WNV isolates, and this represents a
novelty among Western Mediterranean West Nile viruses (Table 5).
This amino acid residue could have phenotypic relevance since it has
been described that P in this position is associated with an increase in
virulence for American crows, while T in this position attenuates
virulence (Brault et al., 2007).
Pathogenicity studies and LD50 estimation in mice
In order to assess whether the proline found in position NS3-
249 in the Spain/2007 WNV would result in an increase in
virulence, we performed a pathogenicity assay in vivo in a mouse
model, which is considered a good correlate of human encephalitis
(Halevy et al., 1994; Beasley et al; 2002; Yamshchikov et al., 2004;
Granwehr et al., 2004). For that we used four strains/isolates:
NY'99-crow, which shows P at NS3-249, and is considered a highly
pathogenic strain; Morocco/2003, a Western Mediterranean strain
with T instead of P in this position, and whose pathogenicity has
not been experimentally assessed before; Spain/2007, showing P at
this position; and ﬁnally B956 (Uganda/1937), the WNV prototype
strain, which belongs to a different lineage (2), with H (histidine)
at this position, and considered less pathogenic than NY'99
(Yamshchikov et al., 2004). High (100%) mortality was observed
with a relatively low dose (100 pfu/mouse) in all isolates analyzed
(Fig. 2a–c), except Uganda/1937, which needed over 1000 pfu/
mouse to kill 66% of the mice (Fig. 2d). However, at lower doses
(1–10 pfu/mouse), differences were observed between Spain/2007
on one hand, which showed lower mortalities (Fig. 2c), and NY'99
or Morocco/2003 on the other hand (Fig. 2a and b, respectively),
with higher mortalities at these doses. The calculated LD50 of WNV
NY99, Morocco/2003, Spain/2007 and Uganda/1937 were, respec-
tively, 2.31, 1.78, 17.78 and 39.32 plaque forming units (pfu)/ml,
whereas the mean survival time ranged between 8.83 andnce in the complete sequence of the polyprotein of different Western Mediterranean
003 France 2004 Spain 2007 Italy 15804/08 Italy 15217/08
—
18 (0.52%) —
15 (0.44%) 15 (0.44%) —
16 (0.47%) 16 (0.47%) 3 (0.09%) —
Table 5
Comparison of amino acid substitutions of the Spain/2007 WNV to different lineage 1 WNV strains (same as in previous tables).
Viral
protein
Amino acid
position
Spain
2007
Italy
1998
Morocco
2003
Morocco
1996
France
2000
France
2004
Italy
2008a
New York
1999
Beaumont
2002
Israel
1998
C 34 Vb M M M M M M M M M
100 S S S S S L S S S S
119 A A A A A T A A A A
prM 35 I I I I I T I I I I
E 51 Tb A A A A A A A A A
76 T T T T T T T T A T
88 Sb P P P P P P P P P
126 T T T T T T T I I I
153 G G G G G R G G G G
159 I I I I I I I V V V
278 T T T T T T T T T T
312 L L L L L F L L L L
442 V V V I V V V V V V
NS1 17 S S S S S S S S S N
35 Hb Y Y Y Y Y Y Y Y Y
45 I I I I V I I I I I
70 S S S S S S S A A A
94 E E E E E E E E G E
138 P P P P P S P P P P
141 K K K K K R K K K K
188 V V I V V V V V V V
208 Hb D D D D D D D D D
288 S S S R S S S S S S
289 Gb E E E E E E E E E
NS2A 85 I I I I I I V I I I
104 I I I I I I I (T) I I I
119 H H Y H H H H H H H
128 E E E E G E E E E E
138 V V V V V V V V I V
165 G G G G G G G G G R
NS2B 82 D D D D D D D D D G
83 G G G G G G G G G E
103 A A A A A A A V V V
120 V I V V V V I (V) V V V
NS3 46 F F L F F F F F F F
244 Q Q Q Q H Q Q Q Q Q
249 P T T A T T P P P P
356 I I I I I I I T T T
496 L L L L L L L L L P
503 N N N N S N N N N N
521 D D D D D D D D D E
NS4A 85 V V V V V V I A A A
100 P P P P P P S P P P
NS4B 115 Tb A A A A A A A A A
173 V V V V V V V V I V
249 D D D D D D D E E E
NS5 53 H H H H H H H (Y) H H H
54 P P P P P P P P P S
257 V V V V V V A V V V
280 K K K K K K K K K N
372 V V V V V V V V V A
374 Y Y Y Y Y H Y Y Y Y
422 R R R R R R K R R R
426 Ab E E E E E E E E E
436 Ib M M M M M M M M M
526 T T T T T T T T I T
681 T T T T I T T T T T
In boldface type, residues common (“signature”) to the American/Israeli cluster that differ from the Western Mediterranean cluster.
a In parenthesis, amino acid residues found in a second isolate, Italy 15217/08, from the same outbreak (GenBank acc. n°: FJ483548).
b Residues found only in the Spain/2007 isolates.
294 E. Sotelo et al. / Virology 395 (2009) 289–2979.93 days in all isolates tested (Table 6). All four viruses were
detected by RT-PCR and recovered by virus isolation from brain
tissue of dead mice, revealing that in all cases the virus was
neuroinvasive (Table 7). Mice surviving doses equal or above 100
pfu (which were only those inoculated with the less virulent B956
strain) had WNV-neutralizing antibodies at 28 dpi. Lower doses
gave variable results: on one hand, one mouse inoculated with 1
pfu B956 still gave relevant WNV-neutralizing Ab titers, whereas
two mice inoculated with 10 pfu Spain/2007 did not give
detectable neutralizing antibodies (Table 7).Discussion
The different epidemiological behaviour of WNV in the Old vs. the
New World is rather intriguing (Kilpatrick et al., 2006; Brault, 2009).
The case of the Western Mediterranean region is paradigmatic among
the Old world, in that very few outbreaks take place, very few clinical
cases are counted, and of those, human cases are extremely rare and
wild bird susceptibility is also exceptional, the main affected species
being the horse. The outbreaks are sporadic and self-limiting. This
behaviour is also reﬂected by the low number of WNV isolates, and
Fig. 2.Mortality found in groups of six mice after inoculation with 1 (closed squares), 10 (open squares), 100 (closed dots) and 1000 (open dots) plaque forming units of (a) WNV
NY'99, (b) WNV Morocco/2003, (c) WNV Spain/2007 and (d) WNV B956.
295E. Sotelo et al. / Virology 395 (2009) 289–297thus, of nucleotide sequences, available from the Western Mediterra-
nean area, which has prevented detailed phylogenetic analyses, that
would help clarifying the epidemiology of this virus in the region. In
particular, it is still unclear whether these Western Mediterranean
WNV strains are derived from a single introduction or, alternatively, if
different introductions have taken place during this period (Charrel et
al., 2003; Hubálek, 2000).
In this paper we provide two new complete nucleotide sequences
from the Western Mediterranean region, corresponding to the ﬁrst
West Nile viruses isolated in Spain, from two golden eagles (A.
chrysaetos). Both isolates are very similar to each other at the
nucleotide level, and completely identical at the amino acid level.
Phylogenetic analysis of complete genomic nucleotide sequences
representative of a wide range of WNV lineage 1 variants clearly
assigned these new isolates to the European–Mediterranean clade
within lineage 1a, as it was already pointed out by preliminary partial
sequence analysis (Jiménez-Clavero et al., 2008). This new phyloge-
netic analysis includes 10 Western Mediterranean West Nile virus
isolates. Of them, four are the most recent from which the complete
nucleotide sequence has been made available: the two Spanish WNV
isolates whose sequences are described in this study, and two new
WNV sequences from Italian viruses isolated in the 2008 outbreaks
(Savini et al., 2008), deposited in GenBank. This new phylogenetic
reconstruction of the Western Mediterranean subclade of WNV
sequences provides relevant information regarding the phylogeny of
this subclade, whose isolates span a period of 13 years, and a territory
about 2.000 km wide, delimited between 34°N to 45°N and−9°W to
13°E. West Nile virus re-emerged in this area at the end of the 1990s
(Murgue et al., 2001a), probably through a new introduction (Parreira
et al., 2007), and since then it has been detected rather sporadically,Table 6
Virulence of four WNV isolates/strains in Swiss mice by the i.p. route.
WNV strain/isolate NS3249 LD50 (pfu) Mean survival time±SD (days)
NY'99 Pro 2.31 8.83±1.17
Morocco 2003 Thr 1.78 9.93±1.86
Spain 2007 Pro 17.78 9.38±1.51
B956 His 39.32 10.55±1.50
The amino acid residue at position 249 in the NS3 protein of each virus is indicated.
LD50: 50% lethal dose.causing limited outbreaks. An older introduction into Western
Mediterranean is represented in the tree shown in Fig. 1a by the
isolate Portugal/71. Unexpectedly, a WNV strain from China shows
similarity with this isolate and the isolate Egypt/51. This would mean
that at least one of these lineage I viruses has dispersed very widely,
but as there is a lack of isolates related to this branch in geographic
areas between Portugal, Egypt and China, this point still needs further
investigation. The close similarity between these Western Mediterra-
nean WNV strains, which constitute a monophyletic group, indicates
that they have a common origin. Whether they have originated from a
single introduction into the Western Mediterranean region, or,
alternatively, have resulted from different introductions from a static
reservoir located outside the region, is still in question.
Migrating birds coming from endemic areas of sub-Saharan Africa
are able to transport WNV into the Western Mediterranean and this is
the most likely way of introduction of WNV into this area (Jourdain et
al., 2007a). Although the virus could have been introduced in this way
repeatedly into Europe, it appears that only in few occasions it has
been successfully established in the wildlife species. This long-
distance bird migration has been involved in the repeated introduc-
tion of WNV into the Middle East in the recent years, but unlike in the
Western Mediterranean, this leads to the detection of heterogeneous
WNV in molecular epidemiology studies (Briese et al., 2002), clearly
pointing out to at least two different introductions. In the case of the
Western Mediterranean region, the sequences found are highly
homogeneous. For instance, while the heterogeneity observed in the
amino acid sequence of the polyprotein of theWesternMediterranean
WNV strains in an 8-year period (between 1996 and 2003) ranged
between 4 and 8 substitutions (0.12–0.23%), in an equivalent period,
in North America, where a single introduction has taken place, these
substitutions ﬂuctuate between 5 and 7 (0.14–0.20%) (Granwehr et al.,
2004). However, three recent Western Mediterranean WNV isolates
(France/2004, Spain/2007 and Italy/2008) show a higher number of
amino acid substitutions, though their “signature” is still of the
Western Mediterranean subclade. These recent strains could likely
have evolved independently from the previous viruses circulating
silently either in the Western Mediterranean area (after a single
introduction) or outside (multiple introductions), but further studies,
in particular, more full-genome analysis of a wider range of WNV
isolates from Europe and Africa, are needed to elucidate this subject.
Table 7
Summary of analytical and mortality data after i.p. inoculation of Swiss mice with four different WNV strains/isolates.
WNV isolate/strain Inoculum (pfu/mouse) Mortality after 2 weeks WNV-neutralizing antibodiesa WNV in brain tissue
D/T % N° pos/analiz. Mean titre (log) RT-PCR Virus isolation
NY'99 102 6/6 100 — — Positive Positive
101 5/6 83 0/1 — Positive n.t.
100 2/6 33 0/3 — Positive n.t.
Morocco 2003 102 6/6 100 — — Positive Positive
101 6/6 100 — — Positive n.t.
100 2/6 33 0/3 — Positive n.t.
Spain 2007 102 6/6 100 — — Positive Positive
101 2/6 33 0/2 — Positive n.t.
100 0/6 0 0/4 — Positive n.t.
B956 103 4/6 66 2/2 1.9 Positive Positive
102 4/6 66 2/2 1.8 Positive n.t.
101 3/6 50 1/3 1.5 Positive n.t.
100 0/6 0 1/6 1.9 Positive n.t.
Control — 0/6 0 0/2 — Negative Negative
D/T: dead/total; n.t.: not tested.
a Determined by virus-neutralization test in survivors at 26–28 days after virus inoculation.
296 E. Sotelo et al. / Virology 395 (2009) 289–297Different raptors, including golden eagles, have been found
susceptible to WNV disease both in North America (Nemeth et al.,
2006) as well as in Europe (Höﬂe et al., 2008; Bakonyi et al., 2006;
Erdélyi et al., 2007). The WNV isolates from golden eagles analyzed in
this work were overtly pathogenic in these hosts, infecting one eagle
lethally, while the other also suffered from disease but slowly
recovered (Jiménez-Clavero et al., 2008). The new Spanish WNV
isolates have proline instead of threonine in position 249 of the
nonstructural protein NS3, like the American/Israeli strains, and as
opposed to most Western Mediterranean isolates, which have
threonine instead. This position is also occupied by proline in the
isolates from the most recent Western Mediterranean outbreak that
occurred in Italy in 2008, which affected hundreds of horses, but also
wild birds and humans (Savini et al., 2008). This is also the case in all
the isolates of the highly pathogenic American/Israeli cluster of WNV.
This amino acid residue has been recently claimed to increase the
virulence of WNV in birds (Brault et al., 2007). In an elegant study,
Brault and colleagues observed that this position is occupied by
proline inmost virulentWNV strains, and showed in awild birdmodel
(American crow) that substituting proline by threonine in highly
pathogenic strains decreased their pathogenicity notably, while doing
the opposite in low pathogenic strains, the virulence increased
correspondingly. As this characteristic is a novelty among theWestern
Mediterranean viruses, it seemed important to assess to what extent
this amino acid change affects the pathogenicity of the Spanish
isolates in different hosts, and to compare it with other WNV isolates
containing either proline or threonine at this position. As a ﬁrst
approach, we chose a widely used mouse model of neurovirulence
(Halevy et al., 1994; Beasley et al., 2002; Yamshikov et al., 2004),
bearing in mind that, although it could not necessarily give the same
results as the wild bird model used by Brault and collaborators, it
would nevertheless be useful to compare the pathogenicity of the
strains analyzed.
Our results demonstrate that among Western Mediterranean
strains, some, such as the Morocco/2003 isolate, which do not have
proline at NS3-249 can be as pathogenic as their North American
counterparts, while others having proline at this position, like the
Spain/2007 isolate, are less pathogenic. Consequently, these results
are relevant in two issues of importance to explain the different
epidemiology observed between North America and the Mediterra-
nean region. On one hand, they do not support the hypothesis that
attributes the higher effect of WNV infection on human and animal
health observed in North America to a higher intrinsic virulence of the
strains circulating there (Kilpatrick et al., 2006), since other WNV
isolates from areas where the disease is sporadic and self-limited, such
as theWestern Mediterranean, show similar or even higher virulence.Alternative hypothesis should be considered to explain the differences
between the Old and New World with regard to WNV eco-
epidemiology, particularly those taking into account the ecology and
the behaviour of host and vectors in the different geographical
locations (Kilpatrick et al., 2006).
On the other hand, our results do not support that the recent
emergence of NS3-249 “proline” WNV variants in the Western
Mediterranean is indicative of a rise in pathogenicity, as this does
not occur for the Spain/2007 isolate examined in this study, at least in
a mouse model. Moreover, our results do not support a role in
pathogenicity for the residue in position NS3-249, since two different
isolates, NY'99 and Morocco/2003, showing either proline or
threonine in this position, respectively, produced similar mortality
in mice and essentially the same LD50 in this model, and, on the other
hand, Morocco/2003 (threonine), is more pathogenic than Spain/
2007 (proline). These two viruses differ in 13 amino acid positions
(Tables 4 and 5). One or more of these changes should be responsible
for the difference in pathogenicity observed.
The apparent disagreement between our present results and the
study by Brault and colleagues (Brault et al., 2007), who performed
their experimental work in American crows, could either mean that
the pathogenicity measured in mice does not correlate with that
measured in a true reservoir host (the American Crow) or that the
strains used in each study were not comparable. While in both studies
NY'99 resulted in high pathogenicity, the Old World WNV was
represented, in the study by Brault and colleagues, by the Kenya KN-
3829 strain and in our study by two strains of different pathogenicity
and whose virulence determinants could differ from those identiﬁed
by Brault et al. Nevertheless, as the pathogenicity in avian hosts could
more likely reﬂect the natural cycle of the virus, experimental studies
using susceptible Europeanwild birds are ongoing in our laboratory to
examine the pathogenicity of the strains analyzed in this work and to
see if the results the virulence observed in mice are supported by an
avian model of the disease.
Conclusions
The study of two new WNV isolates from the Western Mediterra-
nean has shed new light on the eco-epidemiology of this virus in this
region. On one hand, our results show at least two distinguishable
branches in the WNV phylogenetic tree that are circulating in the
WesternMediterranean region, which could have evolved from earlier
strains. However, whether they come from a single introduction or
from repeated introductions from a static reservoir needs further
investigation. On the other hand, intrinsic differences in pathogenicity
of local viral variants, as assessed in a mouse model, do not appear to
297E. Sotelo et al. / Virology 395 (2009) 289–297be a major cause for the higher impact of WNV in North America vs.
that observed in the Old World.
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